Akt activation by growth factors is a multiple-step process: the role of the PH domain
- PMID: 9690513
- DOI: 10.1038/sj.onc.1201947
Akt activation by growth factors is a multiple-step process: the role of the PH domain
Abstract
The protein kinase encoded by the Akt proto-oncogene is activated by phospholipid binding, membrane translocation and phosphorylation. To address the relative roles of these mechanisms of Akt activation, we have employed a combination of genetic and pharmacological approaches. Transient transfection of NIH3T3 cells with wild-type Akt, pleckstrin homology (PH) domain mutants, generated on the basis of a PH domain structural model, and phosphorylation site Akt mutants provided evidence for a model of Akt activation consisting of three sequential steps: (1) a PH domain-dependent, growth factor-independent step, marked by constitutive phosphorylation of threonine 450 (T450) and perhaps serine 124 (S124), that renders the protein responsive to subsequent activation events; (2) a growth factor-induced, PI3-K-dependent membrane-translocation step; and (3) a PI3-K-dependent step, characterized by phosphorylation at T308 and S473, that occurs in the cell membrane and is required for activation. When forced to translocate to the membrane, wild-type Akt and PH domain Akt mutants that are defective in the first step become constitutively active, suggesting that the purpose of this step is to prepare the protein for membrane translocation. Both growth factor stimulation and forced membrane translocation, however, failed to activate a T308A mutant. This, combined with the finding that T308D/S473D double mutant is constitutively active, suggests that the purpose of the three-step process of Akt activation is the phosphorylation of the protein at T308 and S473. The proposed model provides a framework for a comprehensive understanding of the temporal and spatial requirements for Akt activation by growth factors.
Similar articles
-
Distinct activation mechanisms of protein kinase B by growth-factor stimulation and heat-shock treatment.Biochemistry. 2004 Apr 13;43(14):4284-93. doi: 10.1021/bi0498712. Biochemistry. 2004. PMID: 15065872
-
Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.Biochem J. 2003 Apr 15;371(Pt 2):405-12. doi: 10.1042/BJ20021589. Biochem J. 2003. PMID: 12521378 Free PMC article.
-
Kinase activities of c-Mos and v-Mos proteins: a single amino acid exchange is responsible for constitutive activation of the 124 v-Mos kinase.Oncogene. 1995 Feb 16;10(4):623-30. Oncogene. 1995. PMID: 7862439
-
AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.Annu Rev Biochem. 1999;68:965-1014. doi: 10.1146/annurev.biochem.68.1.965. Annu Rev Biochem. 1999. PMID: 10872470 Review.
-
Proto-oncogene TCL1: more than just a coactivator for Akt.FASEB J. 2007 Aug;21(10):2273-84. doi: 10.1096/fj.06-7684com. Epub 2007 Mar 14. FASEB J. 2007. PMID: 17360849 Review.
Cited by
-
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma.PLoS One. 2012;7(5):e36856. doi: 10.1371/journal.pone.0036856. Epub 2012 May 10. PLoS One. 2012. PMID: 22590625 Free PMC article.
-
p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.Immunol Cell Biol. 2015 Sep;93(8):735-43. doi: 10.1038/icb.2015.35. Epub 2015 Mar 10. Immunol Cell Biol. 2015. PMID: 25753393
-
The serum protein profile of early parity which induces protection against breast cancer.Oncotarget. 2016 Dec 13;7(50):82538-82553. doi: 10.18632/oncotarget.12757. Oncotarget. 2016. PMID: 27769065 Free PMC article.
-
Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.J Clin Invest. 2004 Feb;113(3):441-50. doi: 10.1172/JCI20267. J Clin Invest. 2004. PMID: 14755341 Free PMC article.
-
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.Am J Pathol. 2001 Aug;159(2):431-7. doi: 10.1016/s0002-9440(10)61714-2. Am J Pathol. 2001. PMID: 11485901 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources